2
Announcements
Trials
Browse
Landscape
Phase
Phase 1
3
Status
Completed
3
Terminated
2
Suspended
1
Sponsor Class
OTHER
3
Study Type
Interventional
3
Sponsor
Cancer Type
Tumor-Agnostic
1
Gynecologic
1
Gastrointestinal
1
Conditions
Ovarian Neoplasms
1
Neoplasms
1
Gallbladder Neoplasms
1
Fallopian Tube Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Ovarian Epithelial
1
Biliary Tract Neoplasms
1
Interventions
Cyclophosphamide
1499
Cisplatin
1435
Paclitaxel
1340
Radiotherapy
1310
Carboplatin
1267
Gemcitabine
1226
Docetaxel
1133
Bevacizumab
1070
Fluorouracil
906
Doxorubicin
805
Dexamethasone
755
Rituximab
744
Capecitabine
735
Oxaliplatin
709
pembrolizumab
700
Etoposide
679
Irinotecan
639
Filgrastim
624
Cytarabine
587
Nivolumab
586
Leucovorin
583
Vincristine
517
Cetuximab
479
Prednisone
478
Bortezomib
474
Trastuzumab
468
Erlotinib Hydrochloride
467
Surveys and Questionnaires
460
Methotrexate
444
Lenalidomide
436
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
3 trials
Recent
Start date
Enrollment
Completed
×
NUC-1031
×
Clear all
NCT01621854
2024-03-20
ProGem1
Imperial College London
Phase 1
Completed
68 enrolled
NCT02351765
2023-05-17
ABC-08
The Christie NHS Foundation Trust
Phase 1
Completed
21 enrolled
NCT02303912
2021-05-18
ProGem2
Imperial College Healthcare NHS Trust
Phase 1
Completed
25 enrolled